21
Views
13
CrossRef citations to date
0
Altmetric
Reports

Hepatocellular carcinoma is induced by a subnecrogenic dose of diethylnitrosamine in previously fasted‐refed rats

Pages 49-54 | Received 09 Apr 1998, Accepted 15 Jul 1998, Published online: 04 Aug 2009
 

Abstract

We reported elsewhere that diethylnitrosamine (DENA) at 20 mg/kg triggered the development of liver foci infasted‐refed rats. Here we investigate whether liver cancer is induced by this dose of DENA when administered to previously fasted‐refed animals. Fischer 344 rats, fasted for four days, were given 20 mg/kg DENA after one day of refeeding; regularly fed animals receiving 20 or 200 mg/kg DENA were used as negative and positive controls, respectively. The rats were selected by the promoting regimen of Solt and Farber. Focal proliferative lesions, nodules, and carcinomas developed in the liver of fasted‐refed rats given 20 mg/kg DENA and, as expected, in the liver of positive controls. Neither preneoplastic nor neoplastic lesions were found in the negative controls. The liver initiation infasted‐refed rats was steadily irreversible, as reflected by the growth of foci, even when the promoting regimen was postponed. The data show that fasting‐refeeding can substitute for any compensatory proliferative stimulus to make the subnecrogenic dose of DENA able to initiate hepatocytes, eventually leading to the development of liver cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.